Optimized dual promoter AAV gene therapy for lysosomal ßglucocerebrosidase with high M6P content for treatment of neuronopathic Gaucher disease

被引:0
|
作者
Hedman, Andrew [1 ]
Ortmeier, Steven B. [2 ]
Liu, Shou [1 ]
Srnak, Jennifer [1 ]
Zhao, Yicheng [1 ]
White, Katherine [3 ]
Gotshall, Russell [1 ]
Liu, Lin [1 ]
Do, Hung [1 ]
机构
[1] M6P Therapeut, St Louis, MO USA
[2] Sanford Res, Sioux Falls, SD USA
[3] Sanford Hlth, Sioux Falls, SD USA
关键词
D O I
10.1016/j.ymgme.2023.107876
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
137
引用
收藏
页数:1
相关论文
共 5 条
  • [1] Novel dual promoter AAV gene therapy platform ensures production of therapeutic soluble lysosomal enzymes with high M6P content to enable broad cellular uptake and cross correction in vivo
    Hedman, Andrew
    Srnak, Jennifer
    Zhao, Yicheng
    Liu, Shou
    Gotshall, Russell
    Liu, Lin
    Do, Hung
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 58 - 58
  • [2] Novel AAV gene therapy produces beta-glucocerebrosidase with high levels of M6P to enable cellular uptake and cross-correction in the CNS as a potential treatment for type 2/3 Gaucher disease
    Liu, Lin
    Zhao, Yicheng
    Hedman, Andrew
    Srnak, Jennifer
    Liu, Shou
    Gotshall, Russell
    Do, Hung
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 83 - 83
  • [3] A novel AAV9 gene therapy for producing GCase enzyme with high mannose 6-phosphate content to treat Gaucher disease
    Liu, L.
    Hedman, A. C.
    Srnak, J. A.
    Zhao, Y.
    Liu, S.
    Gotschall, R. R.
    Do, H.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A169 - A169
  • [4] Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytes
    Massaro, Giulia
    Hughes, Michael P.
    Whaler, Sammie M.
    Wallom, Kerri-Lee
    Priestman, David A.
    Platt, Frances M.
    Waddington, Simon N.
    Rahim, Ahad A.
    HUMAN MOLECULAR GENETICS, 2020, 29 (12) : 1933 - 1949
  • [5] Generation of β-Glucocerebrosidase variants with increased half-life in human plasma for liver directed AAV gene therapy aimed at the treatment of Gaucher disease type 1
    Comper, Fabrizio
    Yu, I-Mei
    Kalcheva, Petya
    Miranda, Carlos J.
    Chisari, Elisa
    Cocita, Clement
    Correia, Samantha
    Pandya, Jalpa
    Northcott, Natalie
    Stotter, Emmaline
    Shehu, Erald
    Sheridan, Rose
    Nathwani, Amit C.
    Corbau, Romuald
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S27 - S28